| Patient | Frida Kahlo |
|---|---|
| Date of birth | 1989-07-06 |
| Identifiers | MRN HR-NI011-SYN; SSN (made up) 000-11-4390 |
| Document date | 2026-09-17 |
| Author | Marisol Ortega, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chronic post-traumatic back, pelvic, and right leg pain after old spinal and pelvic fractures, spinal surgery, and childhood polio, in a 37-year-old painter on long-term opioid therapy. Please design a multimodal rehabilitation plan, review bracing and orthotics, including a shoe lift for her leg-length difference, and set function goals that can guide a slow opioid taper. [S]
Urgency: Routine, within two weeks. [S]
Questions for the consultant:
Constant low back and pelvic pain with burning in the right leg. It limits how long she can stand at the easel, and she has had to stop teaching at the art school; some students now come to her studio. She walks short distances with a cane and a limp from the shorter, weaker right leg, uses a wheelchair for longer outings, and wears a back brace on bad days. Today's right ankle radiograph shows post-traumatic osteoarthritis, with joint-space narrowing, osteophytes, and healed old fractures. Oxycodone 10 mg up to four times a day (60 MME) for about two and a half years from another prescriber; a single prescriber on the monitoring program and a urine drug test consistent with oxycodone only. She fears a sudden cut in her dose, and any taper will be slow and agreed with her. PEG 7.3; PHQ-9 8 with no thoughts of self-harm; 25-hydroxyvitamin D 18 ng/mL. Started today: duloxetine 30 mg, scheduled acetaminophen, diclofenac gel for the ankle, vitamin D, and naloxone [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day) | One tablet by mouth every 6 hours as needed for pain; no more than 4 tablets a day | Oral route | 2024-03-04 to 2026-10-15 | completed | S |
| Duloxetine 30 mg delayed-release oral capsule, one capsule daily | One capsule by mouth daily | Oral route | 2026-09-17 to 2026-10-01 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily | Two tablets by mouth three times daily; no more than 3,000 mg a day | Oral route | 2026-09-17 | active | S |
| Diclofenac sodium 1% topical gel, 2 g to the right ankle four times daily | Apply 2 g to the right ankle and foot four times daily | Topical route | 2026-09-17 | active | S |
| Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet daily | One tablet by mouth daily | Oral route | 2026-09-17 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostril | For suspected opioid overdose: one spray into one nostril and call 911; if there is no response after 2 to 3 minutes, give a second spray in the other nostril | Nasal route | 2026-09-17 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1925 injuries | active | confirmed | G89.21 | S — Synthetic modern diagnosis linked to the documented injuries; the neuropathic interpretation is R. |
| Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocation | active | confirmed | M19.171 | S — Synthetic diagnosis confirmed on the synthetic ankle X-ray. |
| Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectively | active | provisional | B91 | S — Synthetic modern coding of the documented childhood diagnosis; the alternative remains R. |
| Long-term opioid therapy for chronic pain, 60 MME a day at intake | active | confirmed | Z79.891 | S — Synthetic modern medication status; not a historical assertion. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic finding from the baseline 25-hydroxyvitamin D. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1913 | Poliomyelitis at age six in 1913, leaving the right leg thinner, shorter, and less developed, with the foot turned outward | D (CLM-0003) |
| Proposed in 2006 | Congenital spinal anomaly (spina bifida) proposed retrospectively; not established | R (CLM-0004) |
| September 17, 1925 | Bus and streetcar collision on September 17, 1925: pelvic fracture from a handrail injury through the hip, three spinal fractures, fractured collarbone and two ribs, dislocated right shoulder, and eleven fractures of the right leg with a dislocated foot | D (CLM-0005) |
| After 1925 | Many operations after the accident, some with long convalescences, and about 25 different corsets for posture | D (CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Epilepsy; died in 1941, cause not recorded in the cited source | D (CLM-0012) | |
| mother | Died in 1932; cause not recorded in the cited source | D (CLM-0012) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-17 | Body height | 160 | cm | S |
| 2026-09-17 | Body weight | 50 | kg | S |
| 2026-09-17 | Body mass index (BMI) [Ratio] | 19.5 | kg/m2 | S |
| 2026-09-17 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-09-17 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-09-17 | Heart rate | 82 | /min | S |
| 2026-09-17 | Respiratory rate | 14 | /min | S |
| 2026-09-17 | Body temperature | 36.7 | Cel | S |
| 2026-09-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-17 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-35 U/L | Normal | S |
| 2026-09-17 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-09-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-09-17 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 18 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-09-17 | Mean score [PEG] | 7.3 | {score} | S | ||
| 2026-09-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S |